SCHEMBL30585014

SCHEMBL30585014

CC(C)(C)OC(=O)N1CCC(O)(Cc2ccccn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 3/20 0.54
GPR119 Q8TDV5 3/20 0.51
OPRD1 P41143 2/20 0.48
OPRK1 P41145 1/20 0.48
POLB P06746 1/20 0.47
PKLR P30613 1/20 0.47
GRM5 P41594 2/20 0.45
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
USP30 Q70CQ3 1/20 0.44
DTYMK P23919 1/20 0.43
GRM1 Q13255 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1088021 1.00 CYP46A1 (0.54) CYP46A1GPR119OPRD1OPRK1POLB
SCHEMBL31735206 0.88 GPR119 (0.47) CYP46A1GPR119OPRD1OPRK1POLB
SCHEMBL25400769 0.87 GPR119 (0.50) CYP46A1GPR119OPRD1OPRK1POLB
SCHEMBL20137533 0.87 GPR119 (0.50) GPR119OPRD1OPRK1POLBGRM5
SCHEMBL29506047 0.87 GPR119 (0.50) GPR119OPRD1OPRK1POLBGRM5
SCHEMBL20137772 0.86 GPR119 (0.49) GPR119OPRD1OPRK1POLBGRM5
SCHEMBL25225903 0.86 GPR119 (0.49) CYP46A1GPR119OPRD1OPRK1POLB
SCHEMBL18695971 0.85 GPR119 (0.47) GPR119OPRD1OPRK1POLBGRM5
SCHEMBL25276674 0.85 GPR119 (0.48) GPR119OPRD1OPRK1POLBGRM5
SCHEMBL2904379 0.85 OPRD1 (0.48) GPR119OPRD1OPRK1POLBGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113683610-B RET inhibitor, pharmaceutical composition and application thereof 广东东阳光药业股份有限公司 2025-02-25 CN disclosed
EP-4463452-A2 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2024-11-20 EP disclosed
WO-2023177700-A2 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2023-09-21 WO disclosed